GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $23,324,000 | -25.3% | 532,810 | -25.5% | 0.01% | -26.7% |
| Q1 2022 | $31,243,000 | +25.6% | 714,777 | +26.9% | 0.02% | +15.4% |
| Q4 2021 | $24,867,000 | +14.6% | 563,361 | -0.5% | 0.01% | +30.0% |
| Q3 2021 | $21,706,000 | +1.5% | 566,161 | +5.8% | 0.01% | -9.1% |
| Q2 2021 | $21,393,000 | +174.9% | 535,090 | +150.7% | 0.01% | +120.0% |
| Q1 2021 | $7,783,000 | +52.9% | 213,467 | +59.1% | 0.01% | +66.7% |
| Q4 2020 | $5,090,000 | +11.5% | 134,201 | +8.2% | 0.00% | -25.0% |
| Q3 2020 | $4,565,000 | -15.5% | 124,037 | -7.3% | 0.00% | -20.0% |
| Q2 2020 | $5,402,000 | +46.9% | 133,820 | +37.2% | 0.01% | +25.0% |
| Q1 2020 | $3,678,000 | -66.3% | 97,564 | -58.0% | 0.00% | -50.0% |
| Q4 2019 | $10,927,000 | +6.3% | 232,560 | -3.5% | 0.01% | -11.1% |
| Q3 2019 | $10,281,000 | +46.5% | 240,886 | +37.4% | 0.01% | +50.0% |
| Q2 2019 | $7,016,000 | -9.6% | 175,318 | -5.6% | 0.01% | -14.3% |
| Q1 2019 | $7,764,000 | +66.8% | 185,782 | +52.5% | 0.01% | +75.0% |
| Q4 2018 | $4,655,000 | -14.4% | 121,845 | -10.0% | 0.00% | 0.0% |
| Q3 2018 | $5,436,000 | +1.5% | 135,344 | +1.9% | 0.00% | 0.0% |
| Q2 2018 | $5,354,000 | +0.1% | 132,784 | -3.0% | 0.00% | -20.0% |
| Q1 2018 | $5,346,000 | +15.6% | 136,840 | +4.9% | 0.01% | +25.0% |
| Q4 2017 | $4,626,000 | -59.1% | 130,439 | -53.2% | 0.00% | -60.0% |
| Q3 2017 | $11,321,000 | +71.3% | 278,832 | +82.0% | 0.01% | +66.7% |
| Q2 2017 | $6,607,000 | +22.2% | 153,200 | +19.5% | 0.01% | +20.0% |
| Q1 2017 | $5,407,000 | +21.5% | 128,238 | +8.8% | 0.01% | 0.0% |
| Q4 2016 | $4,452,000 | -11.1% | 117,826 | +1.5% | 0.01% | 0.0% |
| Q3 2016 | $5,008,000 | -1.2% | 116,131 | -0.8% | 0.01% | -16.7% |
| Q2 2016 | $5,071,000 | +28.4% | 117,017 | +20.1% | 0.01% | +50.0% |
| Q1 2016 | $3,950,000 | +7.2% | 97,413 | +6.7% | 0.00% | 0.0% |
| Q4 2015 | $3,685,000 | -5.3% | 91,319 | -9.8% | 0.00% | -20.0% |
| Q3 2015 | $3,893,000 | +16.4% | 101,225 | +26.1% | 0.01% | +25.0% |
| Q2 2015 | $3,344,000 | -5.0% | 80,282 | +5.3% | 0.00% | 0.0% |
| Q1 2015 | $3,519,000 | +2.0% | 76,241 | -5.5% | 0.00% | 0.0% |
| Q4 2014 | $3,450,000 | -13.9% | 80,693 | -7.4% | 0.00% | -20.0% |
| Q3 2014 | $4,006,000 | -37.2% | 87,115 | -27.0% | 0.01% | -28.6% |
| Q2 2014 | $6,383,000 | -56.3% | 119,388 | -56.3% | 0.01% | -63.2% |
| Q1 2014 | $14,593,000 | +130.5% | 273,139 | +130.3% | 0.02% | +111.1% |
| Q4 2013 | $6,332,000 | +5.9% | 118,605 | -0.4% | 0.01% | 0.0% |
| Q3 2013 | $5,977,000 | -23.8% | 119,131 | -24.1% | 0.01% | -35.7% |
| Q2 2013 | $7,843,000 | – | 156,932 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |